Church & Dwight Co., Inc. CHD
Regular-session close
After hours · Nov 13, 5:24 PM ET
- YTD
- +34.76%
- 1 year
- +33.04%
- Market cap
- 26.67B
- Revenue (ttm)
- 6.25B
- Profit margin
- 12.41%
- EPS (ttm)
- 3.26
- Shares out
- 236.03M
- P/E ratio
- 34.66
- Forward P/E
- 27.88
- Dividend
- 1.23 (1.10%)
- Ex-dividend date
- Nov 13, 2026
- YTD return
- +34.76%
- 1-year return
- +33.04%
- Volume
- 1.42M
- Avg volume
- 1.90M
- Open
- 112.26
- Previous close
- 111.42
- Day's range
- 111.62 – 113.25
- 52-week range
- 81.60 – 113.00
- Beta
- 0.45
- Analysts
- Buy
- Price target
- 110.28 (-2.4%)
- Earnings date
- Jan 29, 2027
5D +2.80 (+2.54%)
Key statistics
- Enterprise value
- 28.30B
- PEG ratio
- 3.14
- Price / sales
- 4.27
- Price / book
- 5.98
- Dividend yield
- 1.10%
- Payout ratio
- 37.35%
- Revenue growth
- 1.00%
- Free cash flow
- 777.25M
- Total cash
- 446.90M
- Total debt
- 2.37B
- Return on equity
- 17.80%
- Short % of float
- 5.13%
- 50-day average
- 101.11
- 200-day average
- 98.59
Analyst view
Consensus: buy
- Target (low)
- 78.00
- Target (mean)
- 110.28
- Target (high)
- 124.00
- Strong buy2
- Buy8
- Hold8
- Sell1
- Strong sell1
Next earnings
Jan 29, 2027
Expected Jan 29, 2027. Consensus EPS estimate 1.02.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 29, 2027 | Dec 30, 2026 | 1.01 | — | — | — |
| Oct 30, 2026 | Sep 30, 2026 | 0.90 | 0.92 | +0.02 | +2.22% |
| Jul 31, 2026 | Jun 30, 2026 | 0.896 | 0.89 | -0.01 | -0.67% |
| May 1, 2026 | Mar 31, 2026 | 0.931 | 0.95 | +0.02 | +2.04% |
| Jan 30, 2026 | Dec 31, 2025 | 0.836 | 0.86 | +0.02 | +2.87% |
| Oct 31, 2025 | Sep 30, 2025 | 0.736 | 0.81 | +0.07 | +10.05% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | TD Cowen | main | Hold | Hold |
| Nov 3, 2026 | Barclays | main | Underweight | Underweight |
| Nov 2, 2026 | UBS | main | Neutral | Neutral |
| Nov 2, 2026 | Citigroup | main | Neutral | Neutral |
| Nov 2, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Nov 2, 2026 | JP Morgan | main | Neutral | Neutral |
About Church & Dwight Co., Inc.
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- churchdwight.com
News
PG vs. CHD: Which Consumer Staples Giant Has the Competitive Edge?
Vir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta
Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data
69 Dividend Champions Ranked By Quality Scores (November 2026)
Insider Selling: Church & Dwight (NYSE:CHD) CEO Sells $9,133,230.60 in Stock
Insider Selling: Church & Dwight (NYSE:CHD) CEO Sells $9,133,230.60 in Stock
Nvidia Stock Is Now Cheaper Than a Toilet-Paper Company, Data Shows
NWL vs. CHD: Which Stock Is the Better Value Option? TD Cowen Maintains Hold on Church & Dwight Co, Raises Price Target to $115
Barclays Maintains Underweight on Church & Dwight Co, Raises Price Target to $89
Your note
Sign in to keep a note on CHD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAJAJ RAMAN | Chief Technology Officer | Stock Award(Grant) | Mar 1, 2026 | 16,590 |
| DE MAYNADIER PATRICK D | General Counsel | Stock Award(Grant) | Mar 1, 2026 | 17,951 |
| DIERKER RICHARD A | Chief Executive Officer | Sale | Nov 2, 2026 | 48,019 |
| FARRELL MATTHEW T | Director | Stock Award(Grant) | May 1, 2025 | 160,489 |
| IRWIN BRADLEY C | Director | Sale | Nov 1, 2026 | 37,454 |
| MCCHESNEY LEE B | Chief Financial Officer | Stock Award(Grant) | Mar 8, 2026 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.51% | 22,445,656 | 2.54B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.57% | 15,505,024 | 1.75B | Jun 29, 2026 |
| State Street Corporation | 6.04% | 14,259,895 | 1.61B | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 5.58% | 13,159,991 | 1.49B | Jun 29, 2026 |
| JPMORGAN CHASE & CO | 3.88% | 9,156,829 | 1.03B | Sep 29, 2026 |
| Capital International Investors | 2.90% | 6,850,907 | 774.22M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.19% | 7,523,361 | 850.22M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.60% | 6,141,667 | 694.07M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.18% | 5,134,348 | 580.23M | Jun 29, 2026 |
| ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund | 1.72% | 4,054,850 | 458.24M | Sep 29, 2026 |
| WASHINGTON MUTUAL INVESTORS FUND | 1.67% | 3,935,686 | 444.77M | Sep 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.34% | 3,162,526 | 357.40M | Sep 29, 2026 |
